Effects of dapagliflozin on serum and urinary uric acid levels in patients with type 2 diabetes: a prospective pilot trial

BACKGROUND: We aimed to evaluate the effects of short-term therapy with dapagliflozin on serum uric acid (SUA) and urinary uric acid (UUA) levels in patients with type 2 diabetes. METHODS: In this prospective pilot trial, 8 patients with type 2 diabetes mellitus were assigned to the treatment group...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Tao, Liu, Shixuan, Dong, Yingyue, Fu, Yong, Tang, Yan, Zhao, Weigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590796/
https://www.ncbi.nlm.nih.gov/pubmed/33117454
http://dx.doi.org/10.1186/s13098-020-00600-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590796/
https://www.ncbi.nlm.nih.gov/pubmed/33117454
http://dx.doi.org/10.1186/s13098-020-00600-9

Ejemplares similares